Fri Sep 26 02:10:26 UTC 2025: **News Article:**

**Trump Announces Sweeping New Tariffs, Targeting Pharmaceuticals and More**

Washington D.C. – Former U.S. President Donald Trump announced a series of new tariffs on Thursday, including a potential 100% tariff on imported branded and patented pharmaceutical drugs, set to take effect on October 1, 2025. The move is aimed at incentivizing pharmaceutical companies to build manufacturing plants within the United States.

“Starting October 1st, 2025, we will be imposing a 100 per cent Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump stated on Truth Social. He clarified that “IS BUILDING” would be defined as breaking ground and/or being under construction.

In addition to pharmaceuticals, Trump also announced a 50% tariff on imports of kitchen cabinets and bathroom vanities, 30% on upholstered furniture, and 25% on heavy trucks. He justified the tariffs as necessary “for National Security and other reasons.”

The new tariffs are expected to significantly impact India’s pharmaceutical sector, a major exporter to the United States. In FY24, India exported $8.7 billion worth of pharmaceutical goods to the US, representing 31% of India’s total pharma exports. India supplies over 45% of generic and 15% of biosimilar drugs used in the US. Major Indian pharmaceutical companies like Dr Reddy’s, Aurobindo Pharma, and Sun Pharma derive a significant portion of their revenue from the American market.

While the initial focus appears to be on branded and patented drugs, concerns remain regarding the potential impact on complex generics and specialty medicines from India. Experts warn that higher tariffs could lead to price hikes, inflation, and potential drug shortages for American consumers. Indian companies, already operating on thin margins in the US generics market, may struggle to absorb the increased costs, potentially passing them on to consumers or insurers.

This latest move comes in addition to existing tariffs imposed on Indian imports, including a 25% penalty for continued purchases of Russian oil.

Read More